Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ORKA

Oruka Therapeutics, Inc.

Healthcare | Biotechnology

No licensed closing price on file for ORKA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS$-0.37

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:46 UTC.

What Oruka Therapeutics, Inc. does

Oruka Therapeutics is a clinical-stage biopharmaceutical company formed through the acquisition of Pre-Merger Oruka by ARCA biopharma in August 2024. The company develops monoclonal antibody therapeutics focused on psoriasis and other inflammatory and immunology conditions, with a strategy centered on antibody engineering and format innovations.

Summarized from Oruka Therapeutics, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS$-0.37

Charts

Charts are in the appInteractive charts for ORKA are available in Oxford Ledge.
Open ORKA in Oxford Ledge →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-15
  • 2026-10-15Chief Medical OfficerOption exercise3,500$23.9K
  • 2026-10-15Chief Medical OfficerSale-700$53.7K
  • 2026-10-15Chief Medical OfficerEmployee Warrant (right to buy)Option exercise-3,500—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Oruka Therapeutics, Inc. do?

Oruka Therapeutics is a clinical-stage biopharmaceutical company formed through the acquisition of Pre-Merger Oruka by ARCA biopharma in August 2024.

When did ORKA last file with the SEC?

Oruka Therapeutics, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 07:46 UTC. This page is also available as JSON at /api/data?ticker=ORKA and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ORKA and 5,000+ tickers.

Create a free account — keep ORKA
For your agent
GET /api/data?ticker=ORKA

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt